Report Categories
View AllRecent Articles
View All
Odysightai ODYS Stock vs Competition 323 20260418
Is Cartesian Therapeutics RNAC stock a good pick for capital allocation Q4 2025 EPS Misses Views
PTGX Protagonist Therapeutics Inc rises 217 percent even as Q4 2025 EPS falls far below analyst consensus estimates
The margin expansion playbook at FST KBSX KBSX Q3 Earnings FST Gains 7 on Turnaround Optimism
UI Ubiquiti Inc delivers robust Q1 2026 performance with strong earnings and revenue gains shares rise modestly
CNS CohenSteers shares climb 23 despite earnings miss as revenue rises 77 yearoveryear
Chatham REIT CLDT Risk Reward Ratio Q4 2025 EPS Beats Forecasts
Why Gogoro GGROW might be early to something big Modest Decline 20260508
JDcom JD Bullish Sentiment Emerges as Analyst Upgrades and Hedge Fund Activity Signal Demand Recovery
Why Appian APPN could be the turning point youve been waiting for 774 20260508